-
EP4312977
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4312977
| EP4312977 - NUCLEIC ACID DELIVERY TO THE CENTRAL NERVOUS SYSTEM [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.01.2024 Database last updated on 09.07.2024 | |
| Former | The international publication has been made Status updated on 10.10.2022 | ||
| Former | unknown Status updated on 03.05.2022 | Most recent event Tooltip | 20.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 / US | [2024/06] | Inventor(s) | 01 /
YILDIZ, Hasan, M. Cambridge, MA 02142 / US | 02 /
BORNAPOUR, Mandana Cambridge, MA 02142 / US | 03 /
PENG, Paul Cambridge, MA 02142 / US | 04 /
PATIL, Vishwesh, A. Cambridge, MA 02142 / US | 05 /
SIMLER, Brian, R. Cambridge, MA 02142 / US | 06 /
KIESMAN, William, F. Cambridge, MA 02142 / US | [2024/06] | Representative(s) | Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [2024/06] | Application number, filing date | 22718430.6 | 31.03.2022 | [2024/06] | WO2022US22751 | Priority number, date | US202163169539P | 01.04.2021 Original published format: US 202163169539 P | [2024/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022212648 | Date: | 06.10.2022 | Language: | EN | [2022/40] | Type: | A1 Application with search report | No.: | EP4312977 | Date: | 07.02.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.10.2022 takes the place of the publication of the European patent application. | [2024/06] | Search report(s) | International search report - published on: | EP | 06.10.2022 | Classification | IPC: | A61K9/00, A61K9/51, A61K47/50, C12N15/00 | [2024/06] | CPC: |
A61K9/0085 (EP,US);
C12N15/113 (EP,US);
A61K47/59 (EP,US);
A61K9/0019 (US);
A61K9/5153 (EP,US);
C12N2310/11 (EP,US);
C12N2310/315 (EP,US);
C12N2310/322 (EP,US);
C12N2310/3341 (EP,US);
| C-Set: |
C12N2310/322, C12N2310/3525 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/06] | Extension states | BA | 18.10.2023 | ME | 18.10.2023 | Validation states | KH | 18.10.2023 | MA | 18.10.2023 | MD | 18.10.2023 | TN | 18.10.2023 | Title | German: | NUKLEINSÄUREABGABE AN DAS ZENTRALE NERVENSYSTEM | [2024/06] | English: | NUCLEIC ACID DELIVERY TO THE CENTRAL NERVOUS SYSTEM | [2024/06] | French: | ADMINISTRATION D'ACIDE NUCLÉIQUE AU SYSTÈME NERVEUX CENTRAL | [2024/06] | Entry into regional phase | 18.10.2023 | National basic fee paid | 18.10.2023 | Designation fee(s) paid | 18.10.2023 | Examination fee paid | Examination procedure | 18.10.2023 | Amendment by applicant (claims and/or description) | 18.10.2023 | Examination requested [2024/06] | 18.10.2023 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 20.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2017049709 (HORHOTA ALLEN [US], et al) [X] 1,2,7-10,12,15 * paragraph [0078]; claims 1-35 *; | [X]US2018126014 (ZHOU JIANGBING [US], et al) [X] 1-10,12,15 * paragraph [0036] - paragraph [0038]; claims 1-36 *; | [A]US2019194396 (LU JIAN-MING [US], et al) [A] 1-33 * paragraph [0112]; claim - *; | [A]WO2020056323 (BRIGHAM & WOMENS HOSPITAL INC [US], et al) [A] 1-33 * page 16; examples 1-9; claims 1-59 *; | [XI] - RUDOLPH L. JULIANO, "The delivery of therapeutic oligonucleotides", NUCLEIC ACIDS RESEARCH, GB, (20160415), vol. 44, no. 14, doi:10.1093/nar/gkw236, ISSN 0305-1048, pages 6518 - 6548, XP055491290 [X] 1-4,7-12,15,16,19-25,27-33 * the whole document * [I] 13,14,17,18,26 DOI: http://dx.doi.org/10.1093/nar/gkw236 | by applicant | EP0427185 | US5587361 | US5599797 | US5610266 | US6143881 | US6706854 | EP1468035 | WO2007009919 | EP1907023 | EP2147036 | EP2263707 | US9683235 | US10385341 | US10407680 | - EVERS et al., Advanced Drug Delivery Reviews, (20150000), vol. 87, pages 90 - 103 | - BENNETT et al., Annu. Rev. Pharmacol. Toxicol., (20210000), vol. 61, pages 831 - 52 | - SILVA et al., Brain, (20200000), vol. 143, pages 407 - 429 |